Progress in Cardiovascular Diseases
Volume 52, Issue 5 , Pages 410-428, March 2010

Matrix Metalloproteinases in Atherothrombosis

  • Magnus Bäck

      Affiliations

    • Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    • Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationAddress reprint requests to Magnus Bäck, MD, PhD, Karolinska University Hospital, CMM L8:03, 171 76 Stockholm, Sweden and Stefan Agewall MD, PhD, University of Oslo, 0514 Oslo, Norway.
  • ,
  • Daniel F.J. Ketelhuth

      Affiliations

    • Department of Medicine, Karolinska Institutet, Stockholm, Sweden
  • ,
  • Stefan Agewall

      Affiliations

    • Department of Medicine, Aker University Hospital and Oslo University, Oslo, Norway
    • Corresponding Author InformationAddress reprint requests to Magnus Bäck, MD, PhD, Karolinska University Hospital, CMM L8:03, 171 76 Stockholm, Sweden and Stefan Agewall MD, PhD, University of Oslo, 0514 Oslo, Norway.

Abstract 

The metalloproteinases (MMPs, matrixins) are zinc-containing endopeptidases involved in the metabolism of extracellular matrix as well as in the cleavage of other proteins. The MMP family currently consists of 28 enzymes with somewhat different activities. The members are in part categorized into groups according to either structure or preferred substrates and referred to as collagenases, gelatinases, stromelysins, matrilysins, and membrane-bound MMPs. The proteinase activities exerted by 11 of the 28 MMPs have been implicated in some of the biologic processes associated with atherosclerosis and its ischemic clinical manifestations such as myocardial infarction and stroke. For example, several of the MMPs are locally expressed within human atherosclerotic lesions. However, association studies of subclinical atherosclerosis have generated contradictory results in the role of MMP activities. In addition, circulating MMP levels as well as genetic variations within the genes encoding the different enzymes have been associated with both an increased and decreased cardiovascular risk. Finally, experimental studies of hyperlipemic mice and vascular injury have suggested some of the MMPs function as modulators of atherogenesis, vascular remodeling, and plaque rupture.

Abbreviations and Acronyms: 5A, 5 adenosines, 6A, 6 adenosines, ApoE, apolipoprotein E, ApoE−/−, ApoE knockout, CAD, coronary artery disease, CRP, C-reactive protein, ET-1, endothelin-1, IFN-γ, interferon gamma, IL-10, interleukin 10, IL1-β, interleukin β, IL-4, interleukin 4, IL-6, interleukin 6, IL-8, interleukin 8, LPS, lipopolysaccharide, MI, myocardial infarction, MMP, matrix metalloproteinase, mRNA, messenger ribonucleic acid, NGAL, neutrophil gelatinase-associated lipocalin, PAOD, peripheral arterial occlusive disease, SMC, smooth muscle cell, SNP, single-nucleotide polymorphism, TGF-β1, transforming growth factor β-1, TIMP, tissue inhibitor of metalloproteinases, TNF-α, tumor necrosis factors-α, UA, unstable angina

Keyword: Atherosclerosis, Collagenase, Gelatinase, Inflammation, Lipoxygenase, Myocardial infarction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Statement of Conflict of Interest: see page 422.

PII: S0033-0620(09)00118-2

doi:10.1016/j.pcad.2009.12.002

Progress in Cardiovascular Diseases
Volume 52, Issue 5 , Pages 410-428, March 2010